Isoforskolin Inhibits Lipopolysaccharide Activation of the TLR4/MyD-88/NF-κB Pathway in Small Airway Epithelial Cells
Isoforskolin Inhibits Lipopolysaccharide Activation of the TLR4/MyD-88/NF-κB Pathway in Small Airway Epithelial Cells
复制标题
异毛喉素抑制小气道上皮细胞中 TLR4/MyD-88/NF-κB 通路的脂多糖激活
DOI:
10.29011/2575-789x.000151
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Weimin Yang
中科院分区:
文献类型:
--
作者:
Xiaohua Du;Chen Chen;Yin Huang;Peihua Peng Shibo Sun XiulinYe Ling Li;Zelan Dai Xiaoyue Xiao;Zhiying Weng;Weimin Yang
Abstract.Object: Isoforskolin (ISOF) is isolated from the plant Coleus forskohlii, native to Yunnan China, which has attracted much attention for its biological effects. It has been demonstrated to attenuate inflammation of rat ALI induced by Lipopolysaccharide (LPS). In this study, we hypothesize that ISOF inhibits a main pathway activated by LPS in human small airway epithelial cells (BEAS-2B): cascade of toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88), and nuclear factor kappa-B (NF-κB) signaling..Methods: BEAS-2B cells were pretreated with ISOF (1.0μM), forskolin (FSK, 1.0μM), roflumilast (RF, 1.0μM) and dexamethasone (DEX, 50μM) prior to LPS (2 μg/mL). Protein and mRNA levels of TLR4, MyD88, and NF-κB in BEAS-2B were determined using Western blot and Real-time quantitative PCR. Effects of ISOF and LPS on cell viability were tested by using MTT method..Results: Our results showed that LPS augmented the protein and mRNA levels of TLR4, MyD88, and NF-κB in BEAS-2B cells. Following LPS treatment, protein and mRNA levels of TLR4, MyD88, NF-κB in BEAS-2B decreased significantly. Pretreatment with ISOF attenuated the effects of LPS. Moreover, ISOF (with dose < 5.0 μM) and LPS (with dose < 20 μg/mL) has no effect on cell viability of BEAS-2B at 6h..Conclusions: These results have shown that ISOF inhibits TLR4/MyD88/NF-κB signal pathway, which is activated by LPS, through down-regulation of mRNA and protein levels of TLR4, MyD88 and NF-κB in BEAS-2B.